Galmed Pharmaceuticals (GLMD) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2024)
Galmed Pharmaceuticals (GLMD) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
-17.10% |
| Dec 31, 2023 |
-15.62% |
| Sep 30, 2023 |
-20.71% |
| Jun 30, 2023 |
-23.66% |
| Mar 31, 2023 |
-59.03% |
| Dec 31, 2022 |
-25.33% |
| Sep 30, 2022 |
-25.95% |
| Jun 30, 2022 |
-26.50% |
| Mar 31, 2022 |
-27.20% |
| Dec 31, 2021 |
-27.38% |
| Sep 30, 2021 |
-27.91% |
| Jun 30, 2021 |
-27.96% |
| Mar 31, 2021 |
-28.02% |
| Sep 30, 2020 |
-27.88% |
| Jun 30, 2020 |
-29.71% |
| Mar 31, 2020 |
-26.93% |
| Sep 30, 2019 |
-25.66% |
| Jun 30, 2019 |
49.63% |
| Mar 31, 2019 |
60.04% |
| Dec 31, 2018 |
71.70% |
